Literature DB >> 18566818

[11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy.

Sven N Reske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18566818     DOI： 10.1007/s00259-008-0839-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer.

Authors:  Bernhard Scher; Michael Seitz; Wolfram Albinger; Reinhold Tiling; Michael Scherr; Hans-Christoph Becker; Michael Souvatzogluou; Franz-Josef Gildehaus; Hans-Jürgen Wester; Stefan Dresel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-24       Impact factor: 9.236

2.  Imaging prostate cancer with 11C-choline PET/CT.

Authors:  Sven N Reske; Norbert M Blumstein; Bernd Neumaier; Hans-Werner Gottfried; Frank Finsterbusch; Darius Kocot; Peter Möller; Gerhard Glatting; Sven Perner
Journal:  J Nucl Med       Date:  2006-08       Impact factor: 10.057

3.  Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.

Authors:  Sandi A Kwee; Hai Wei; Isabell Sesterhenn; David Yun; Marc N Coel
Journal:  J Nucl Med       Date:  2006-02       Impact factor: 10.057

4.  [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy.

Authors:  Giampiero Giovacchini; Maria Picchio; Elisa Coradeschi; Vincenzo Scattoni; Valentino Bettinardi; Cesare Cozzarini; Massimo Freschi; Ferruccio Fazio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-16       Impact factor: 9.236

Review 5.  Imaging prostate cancer: a multidisciplinary perspective.

Authors:  Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105
  5 in total
  5 in total

Review 1.  Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.

Authors:  Hossein Jadvar
Journal:  J Nucl Med       Date:  2010-12-13       Impact factor: 10.057

2.  [18F]fluoromethyl-[1,2-2H4]-choline: a novel radiotracer for imaging choline metabolism in tumors by positron emission tomography.

Authors:  Julius Leyton; Graham Smith; Yongjun Zhao; Meg Perumal; Quang-De Nguyen; Edward Robins; Erik Arstad; Eric O Aboagye
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

3.  Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.

Authors:  Sebastian A Müller; Korbinian Holzapfel; Christof Seidl; Uwe Treiber; Bernd J Krause; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-08       Impact factor: 9.236

Review 4.  Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?

Authors:  Julia R Murray; Helen A McNair; David P Dearnaley
Journal:  Cancer Manag Res       Date:  2015-11-11       Impact factor: 3.989

Review 5.  Positron emission tomography in prostate cancer: An update on state of the art.

Authors:  Chandan Jyoti Das; Abdul Razik; Sanjay Sharma
Journal:  Indian J Urol       Date:  2018 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.